Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.

Source:http://linkedlifedata.com/resource/pubmed/id/19272650

Download in:

View as

General Info

PMID
19272650